Turnstone Biologics is a privately-held clinical stage biotech company.
Turnstone Biologics is a privately-held clinical-stage biotech company. Turnstone Biologics’ mission is to deliver breakthrough cancer immunotherapies by advancing two leading and complementary platforms targeting tumor immunity, to improve survival for people with cancer.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 14, 2021 | Series D | $79.99M | 2 | — | — | Detail |
| Dec 19, 2019 | Corporate Round | — | 1 |
Takeda
|
— | Detail |
| Nov 2, 2016 | Series B | $41.40M | 1 | — | — | Detail |
| Oct 27, 2015 | Series A | $11.30M | 1 |
Versant Ventures
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Takeda
|
Yes | Corporate Round |
Northleaf Capital Partners
|
— | Series D |
Versant Ventures
|
— | Series D |